Physician profile
Yoo Suh
NPI 1194713131
$647.72
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2021: $63.20 · 2022: $149 · 2023: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $150.32 | 2021-2023 | Stelara, Simponi, Remicade |
| Abbvie INC. | $139.92 | 2022-2023 | Rinvoq, Skyrizi |
| Janssen Scientific Affairs, LLC | $133.67 | 2023 | Stelara |
| Allergan, INC. | $58.42 | 2019 | |
| Pfizer INC. | $36.16 | 2021 | |
| Gilead Sciences, INC. | $30.10 | 2019 | |
| Shire North American Group INC | $17.30 | 2019 | |
| Mylan Specialty L.P. | $16.01 | 2022 | |
| Redhill Biopharma INC. | $15.48 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.35 | 2022 | |
| Intercept Pharmaceuticals, INC. | $14.31 | 2019 | |
| Amarin Pharma, INC. | $11.10 | 2019 | |
| Daiichi Sankyo INC. | $10.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yoo Suh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.